Completed Research Projects

Title: Randomized, Controlled Trial for Combination Treatment with Pyridostigmine, DEET, and Permethrin
Synopsis: This study evaluated the effects of pyridostigmine bromide, permethrin, DEET, and stress on brain functions.
Overall Summary: See project objective.
Overall Project Objective: Determine the short-term safety and neurocognitive effects of combined treatment with standard application of DEET to skin, permethrin to uniforms, and Pyridostigmine bromide tablets 30 mg TID as employed for nerve agent prophylaxis, under stress and rest conditions.
Results to Date: Forty-seven subjects have provided informed consent and completed a baseline assessment. Twenty of them have completed the study, eight have withdrawn without completion due to schedule difficulties, and another nineteen are at various points in the course of the study. Two subjects are family members of active duty members, the remainder are active duty service members. Not including subjects who withdrew, thirteen are female; 24 are Caucasian, 9 are African-American, 4 are Asian, and 2 are Latino. The average age of subjects is 27. There have been no significant adverse effects to date. Preliminary results include: 1. Pyridostigmine bromide (PB), DEET, and permethrin can be rapidly and sensitively assayed in human plasma samples. 2. Permethrin applied to Battle Dress Uniforms does not enter the bloodstream at detectable levels, whereas DEET applied to the skin, and PB ingested orally, are readily detectable. 3. Combined exposure to PB, DEET, and permethrin does not appear to have significant effects on physical or neurocognitive performance, whether under stress or rest conditions. However, it must be emphasized that this is based upon a limited number of subjects at this point, and it will only be upon completion of the entire study that we expect to have sufficient power to be able to say this with confidence.
Project: DOD-124
Agency: Department Of Defense
Location: The Henry M. Jackson Foundation
P.I. Name: Michael J Roy
Status: Complete
Study Start Date: October 01, 2000
Estimated Completion Date: April 30, 2005
Specific Aims: To determine the safety of combination treatment with DEET, Permethrin and Pyridostigmine.
Methodology: A prospective double-blinded placebo-controlled trial involving 64 subjects at 2 sites. Cross-over designed in which all subjects receive all possible combinations of treatment, placebo, stress, and rest.
Publications:
Cherstniakova S A, Garcia G E, Strong J , Bi D , Weitz J , Roy M J, Cantilena L R. Rapid determination of N,N-diethyl-m-toluamide and permethrin in human plasma by gas chromatography-mass spectrometry and pyridostigmine bromide by high-performance liquid chromatography.J Anal Toxicol.2006;30:21-6.

Roy M J, Kraus P L, Cooper J A, Cherstniakova S A, Coll R , Seegers C A, Deuster P A, Koslowe P , Law W A, Krantz D S, Cantilena L . Initial evaluation of N,N-diethyl-m-toluamide and permethrin absorption in human volunteers under stress conditions.Mil Med.2006;171:122-7.




http://fhp.osd.mil is the official Web site of Force Health Protection & Readiness Policy & Programs
Skyline 4, Suite 901, 5113 Leesburg Pike, Falls Church, VA 22041
The appearance of external hyperlinks does not constitute endorsements by the
Force Health Protection & Readiness Programs of the linked web sites, or the information,
products or services contained therein.

Privacy Policy I Webmaster I DeployMed Feedback

DeployMed ResearchLINK was last updated on 2008-10-03